Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial
Titel:
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial
Auteur:
Johnston, Stephen RD Kilburn, Lucy S Ellis, Paul Dodwell, David Cameron, David Hayward, Larry Im, Young-Hyuck Braybrooke, Jeremy P Brunt, A Murray Cheung, Kwok-Leung Jyothirmayi, Rema Robinson, Anne Wardley, Andrew M Wheatley, Duncan Howell, Anthony Coombes, Gill Sergenson, Nicole Sin, Hui-Jung Folkerd, Elizabeth Dowsett, Mitch Bliss, Judith M
Verschenen in:
Lancet oncology
Paginering:
Jaargang 14 (2013) nr. 10 pagina's 10 p.
Jaar:
2013
Inhoud:
Uitgever:
Johnston et al. Open Access article distributed under the terms of CC BY-NC-SA